According to researchers from King's College London, using electronic cigarettes increases the success rate of attempts to quit smoking to 65%, compared to less than 59% for other smoking cessation methods.
The report states that "vaping only poses a small portion of the risks of smoking" and "significantly reduces the amount of harmful substances inhaled.
Researchers measured biological changes associated with cancer risk, respiratory and cardiovascular disease risk. However, they stated that more evidence is needed to prove the potential long-term effects of e-cigarette use.
This report could lead to electronic cigarettes being prescribed as a tool to quit smoking under the National Health Service. In October 2021, the country's drug regulatory agency updated its guidance to allow manufacturers of electronic cigarettes to apply for licenses for their nicotine-containing products as a medication to help people quit smoking.
Scientists reviewing the study stated that, given the short- and medium-term beneficial effects on health and the fact that it has become a popular alternative to traditional cigarettes, they are willing to endorse a prescription program for electronic cigarettes.
According to Leoni Brooks, a researcher at King's College London and one of the authors of the report, smokers who continue smoking every year can expect to lose approximately three months of their life expectancy. She expressed uncertainty about the need for various steps before attempting effective smoking cessation methods that have already been found.
Despite this, scientists state that electronic cigarettes are not without risk, especially for those who have never smoked before. Research has also found that people who use electronic cigarettes have a higher chance of being exposed to certain carcinogens compared to those who do not smoke or use electronic cigarettes. Among adults who have never smoked, only a very small percentage (0.6% to 0.7%) have started using electronic cigarettes.
According to Professor Lion Shahab from University College London, who co-leads a research team on tobacco and alcohol, the latest report suggests that "healthcare services and policy makers should be reassured that encouraging smokers who are unable to quit to switch to these reduced-risk products will benefit public health.
Statement:
This article is compiled from third-party information and is for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is for industry communication and research purposes only.
Due to limitations in translation proficiency, the translated article may differ in expression from the original. Please refer to the original text for accuracy.
2FIRSTS maintains full alignment with the Chinese government concerning any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
Copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
